Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH. (Q46505945)
Jump to navigation
Jump to search
scientific article published on 18 June 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH. |
scientific article published on 18 June 2008 |
Statements
1 reference
Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH. (English)
1 reference
Axel Hauschild
1 reference
Friederike Egberts
1 reference
Andrea Pollex
1 reference
Jan-Hendrik Egberts
1 reference
Katharina C Kaehler
1 reference
Michael Weichenthal
1 reference
18 June 2008
1 reference
1 reference
31
1 reference
7
1 reference
380-384
1 reference
Identifiers
1 reference